* AMN Healthcare Services Inc AMN.N AMN is expected
to show a
rise in quarterly revenue when it reports results on November
3.
* The Dallas Texas-based company is expected to report a
25.2% increase in revenue to $1.099 billion from $877.8 million
a year ago, according to the mean estimate from 8 analysts,
based on Refinitiv data. The company's guidance on August 4
2022, for the period ended September 30, was for revenue between
1.08 billion and 1.11 billion.
* Refinitiv's mean analyst estimate for AMN Healthcare
Services
Inc is for earnings of $2.37 per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for AMN
Healthcare
Services Inc is $131, above its last closing price of $127.04.
The company's guidance on August 4 2022 for the period ended
September 30 was for Earnings before Interest and Taxes between
127.44 million and 137.64 million.The company's guidance on
August 4 2022 for the period ended September 30 was for Earnings
before Interest, Taxes, Depreciation and Amortization of between
1.08 billion and 177.6 million.The company's guidance on August
4 2022 for the period ended September 30 was for gross profit
margin between 33% and 33.5%.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2022 2.99 2.97 3.31 Beat 11.6
Mar. 31 2022 3.22 3.20 3.49 Beat 9
Dec. 31 2021 2.77 2.66 2.95 Beat 11.1
Sep. 30 2021 1.31 1.30 1.73 Beat 32.7
Jun. 1.43 1.43 1.64 Beat 14.9
30 2021
Mar. 31 2021 1.37 1.37 1.70 Beat 24.3
Dec. 31 2020 0.90 0.88 1.00 Beat 13.3
Sep. 30 2020 0.70 0.69 0.82 Beat 18.6
This summary was machine generated November 2 at 02:12 GMT. All
figures in US dollars unless otherwise stated